Filing Details
- Accession Number:
- 0001209191-21-026874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-15 19:12:52
- Reporting Period:
- 2021-04-08
- Accepted Time:
- 2021-04-15 19:12:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1678660 | Prelude Therapeutics Inc | PRLD | Pharmaceutical Preparations (2834) | 811384762 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1824631 | Christopher Pierce | C/O Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803 | Evp And Chief Of Business Oper | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-08 | 200 | $1.89 | 3,950 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-04-08 | 200 | $40.00 | 3,750 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-04-08 | 200 | $0.00 | 200 | $1.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,618 | 2030-03-26 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The stock option is fully vested.